Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial (Q38135798)
Jump to navigation
Jump to search
scientific article published on 09 September 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial |
scientific article published on 09 September 2013 |
Statements
1 reference
Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial (English)
1 reference
Robert J Motzer
1 reference
David Cella
1 reference
Cezary Szczylik
1 reference
Cora N Sternberg
1 reference
Dmitry Nosov
1 reference
Timothy Eisen
1 reference
Igor Bondarenko
1 reference
Vladimir Lesovoy
1 reference
Oleg Lipatov
1 reference
Piotr Tomczak
1 reference
Oleksiy Lyulko
1 reference
Anna Alyasova
1 reference
Mihai Harza
1 reference
Mikhail Kogan
1 reference
Boris Y Alekseev
1 reference
Cristina Ivanescu
1 reference
Andrew Krivoshik
1 reference
Andrew Strahs
1 reference
Brooke Esteves
1 reference
Anna Berkenblit
1 reference
Thomas E Hutson
1 reference
9 September 2013
1 reference
1 reference
3791-3799
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference